Ancora.ai logo — Ancora.ai is a patient-first, digital clinical trial navigat...

Ancora.ai

Ancora.ai is a patient-first, digital clinical trial navigation tool connecting cancer patients to clinical trials.

Founded 2017 Switzerland Zurich, Switzerland 9 employees Grant Total: $465.00K AI, Big Data +3

General Information

Company Name Ancora.ai
Founded Year 2017
Location Switzerland Zurich, Switzerland +3
Employees 9
Industries AI, Big Data, Health Care +2
Funding Stage Grant
Social

Get notified when Ancora.ai moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Ancora.ai

Ancora.ai is a Switzerland-based startup with a vision to revolutionize cancer patient care by providing access to clinical research through their patient-first, digital clinical trials hub. Their precision medicine trial matching technology personalizes trial results for cancer patients in minutes, reducing the burden of clinical trial referrals across the healthcare ecosystem and accelerating recruitment timelines. Recently, they secured a Fr.30.00K grant investment from Future of Health Grant in February 09, 2023. Ancora.ai is committed to democratizing access to trials, and they are actively seeking strong partners who share their vision to bring innovation and improved accessibility to clinical trials. Their focus on Big Data, Health Care, Pharmaceutical, and SaaS industries underlines their commitment to utilizing advanced technology for the benefit of cancer patients worldwide. Follow their journey on Twitter at @ancora_ai and Instagram at @ancora.ai.

Taxonomy: AI-driven, digital clinical trials, precision medicine, patient centricity, health equity, oncology, cancer, neural networks, deep learning, personalized medicine, NLP, clinical trial recruitment

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1 •••• •••• 09 Feb 2023
Non Equity Assistance •••••• 1 •••• •••• 15 Jun 2022
Pre Seed Round •••••• - 31 Oct 2021
Grant •••••• 1 •••• •••• 26 Jun 2020
Grant •••••• - 26 May 2020

View All 6 Funding Rounds

Ancora.ai Alternatives & Competitors

Ancora.ai vs
iClusion
iClusion The Netherlands

Access to clinical trials: Serving professionals with the Trial-Eye infrastructure and patients with...

1 employees
Care Economy, Health Care
Ancora.ai vs

Changing the way communities fight cancer.

21 employees
Health Care
Ancora.ai vs

Conquering melanoma and skin cancer through clinical trials.

16 employees
Also compare with: Ancora.ai vs Leal Health Leal Health

FAQ About Ancora.ai

Ancora.ai is a patient-first, digital clinical trial navigation tool connecting cancer patients to clinical trials.
Ancora.ai was founded in 2017.
Ancora.ai is headquartered in Zurich, Switzerland.
Ancora.ai operates in the following industries: AI, Big Data, Health Care, Pharmaceutical, SaaS.
Ancora.ai has approximately 9 employees.
Ancora.ai has completed 6 funding rounds, raising a total of $465.00K. The latest funding stage is Grant.
Top alternatives and competitors to Ancora.ai include iClusion, Lazarex Cancer Foundation, Melanoma and Skin Cancer Trials, Leal Health, Clinical Trials Transformation Initiative (CTTI). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Ancora.ai and iClusion are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Ancora.ai and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes